Neurological manifestations of COVID-19 in adults and children
Sung‐Min Cho(Highways England), João Melo Alves, Jacky Y. Suen(The University of Queensland), Lavienraj Premraj(Griffith University), David Thomson(Colorado State University), Shakeel Ahmed, Clotilde Allavena(Centre Hospitalier Universitaire de Nantes), Nurul Najmee Abdulkadir, João Alves, Takako Akimoto, Senthilkumar Alegesan, Ali Ait Hssain, John F. Fraser(The University of Queensland), Jonathon P. Fanning(The University of Queensland), Rita de Cássia Loiola Alves, Younes Ait Tamlihat(Imation (United States)), Bhagteshwar Singh(University of Liverpool), Abdulrahman Al‐Fares(Amiri Hospital), Aneela Altaf, Kate Ainscough, Ernita Akmal, Lara Absil, Qabas Alkhafajee, Nathalie Allou, Kévin Alexandre, Cynthia Alegre, Nicole White(Queensland University of Technology), Huda Alfoudri(Adan Hospital), Naseem Ali Shah, Laura Merson, Razi Alalqam(University of Oxford), Chiara Robba(Ospedale Policlinico San Martino), Tala Al-dabbous, Ryuzo Abe, Diana Adrião, Griffee Mb(University of Utah), Laurent Abel(Inserm), gt Barbara Wanjiru Citarella(University of Oxford), Ali Abbas(University of Dundee), Imran Ali, Subhash Prasad Acharya, Tom Solomon(University of Liverpool), Tharwat Aisa, Saleh Al Ageel, Andrew Acker, Beatrice Alex, Kazali Enagnon Alidjnou, Jeffrey Aliudin, Denise Battaglini(Universitat de Barcelona), G Li Bassi(Queensland University of Technology)
Cited by 84
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
TLR3 Deficiency in Patients with Herpes Simplex Encephalitis
|Science|2007|1.1k
Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I
|The Journal of Experimental Medicine|2010|721